更多...
收起
CTNNB1基因(以及对应的蛋白质)的细胞分布位置:
CTNNB1基因的本体(GO)信息:
疾病名称 | 关系值 | NofPmids | NofSnps | 来源 |
Pilomatrixoma | 0.481628651 | 7 | 6 | BeFree_CLINVAR_CTD_human_ORPHANET_UNIPROT |
Medulloblastoma | 0.36706742 | 19 | 1 | BeFree_CLINVAR_CTD_human_LHGDN_UNIPROT |
MENTAL RETARDATION, AUTOSOMAL DOMINANT 19 | 0.36 | 1 | 4 | CLINVAR_ORPHANET_UNIPROT |
Liver carcinoma | 0.282629813 | 68 | 2 | BeFree_CLINVAR_CTD_human_GAD_LHGDN |
Colorectal Neoplasms | 0.263031187 | 31 | 0 | BeFree_CTD_human_GAD_LHGDN_RGD |
Hepatoblastoma | 0.247338862 | 18 | 3 | BeFree_CLINVAR_CTD_human_LHGDN |
Craniopharyngioma | 0.241357209 | 5 | 1 | BeFree_CTD_human_ORPHANET |
ovarian neoplasm | 0.240542884 | 3 | 1 | BeFree_CLINVAR_CTD_human |
Colonic Neoplasms | 0.231596504 | 27 | 0 | BeFree_CTD_human_LHGDN_RGD |
Lung Neoplasms | 0.205720142 | 5 | 2 | BeFree_CTD_human_LHGDN_RGD |
Malignant neoplasm of prostate | 0.202171535 | 8 | 1 | BeFree_CLINVAR_MGD |
Malignant neoplasm of ovary | 0.200542884 | 3 | 9 | BeFree_MGD_UNIPROT |
Colorectal Cancer | 0.142149951 | 43 | 1 | BeFree_GAD_UNIPROT |
Prostatic Neoplasms | 0.142066244 | 9 | 0 | BeFree_CTD_human_LHGDN |
Mammary Neoplasms | 0.137160427 | 10 | 0 | BeFree_CTD_human_LHGDN |
Adenocarcinoma | 0.135521844 | 15 | 0 | BeFree_CTD_human_LHGDN |
Adenoma | 0.135240471 | 22 | 1 | BeFree_CTD_human_LHGDN |
Liver neoplasms | 0.1289015 | 9 | 0 | BeFree_CTD_human_GAD_LHGDN |
Nephroblastoma | 0.127805801 | 11 | 0 | BeFree_CTD_human_GAD_LHGDN |
Pancreatic Neoplasm | 0.125634266 | 5 | 0 | BeFree_CTD_human_GAD_LHGDN |
Colon Carcinoma | 0.124071628 | 15 | 2 | BeFree_CLINVAR |
Malignant lymphoma, lymphocytic, intermediate differentiation, diffuse | 0.12272435 | 1 | 0 | CTD_human_LHGDN |
Liver Cirrhosis | 0.120814326 | 4 | 0 | BeFree_CTD_human |
Intestinal Neoplasms | 0.120542884 | 3 | 0 | BeFree_CTD_human |
Hepatocellular Adenoma | 0.120542884 | 3 | 0 | BeFree_CTD_human |
Adrenocortical carcinoma | 0.120542884 | 3 | 0 | BeFree_CTD_human |
Adrenal Gland Neoplasms | 0.120271442 | 2 | 0 | BeFree_CTD_human |
Uterine Cervical Neoplasm | 0.120271442 | 2 | 0 | BeFree_CTD_human |
Cecal Neoplasms | 0.12 | 1 | 0 | CTD_human |
Hemangiosarcoma | 0.12 | 1 | 0 | CTD_human |
Liver Neoplasms, Experimental | 0.12 | 3 | 0 | CTD_human |
Muscular Atrophy | 0.12 | 1 | 0 | CTD_human |
Neoplasm Invasiveness | 0.12 | 1 | 0 | CTD_human |
Nerve Degeneration | 0.12 | 1 | 0 | CTD_human |
Stevens-Johnson Syndrome | 0.12 | 1 | 0 | CTD_human |
No-Reflow Phenomenon | 0.12 | 1 | 0 | CTD_human |
Craniofacial Abnormalities | 0.12 | 1 | 0 | CTD_human |
Drug-Induced Liver Injury | 0.12 | 1 | 0 | CTD_human |
Desmoid disease, hereditary | 0.12 | 0 | 0 | ORPHANET |
Aberrant Crypt Foci | 0.12 | 3 | 0 | CTD_human |
Desmoid Tumor Caused By Somatic Mutation | 0.12 | 0 | 1 | CLINVAR |
Alzheimer's Disease | 0.082995792 | 3 | 0 | BeFree_LHGDN_RGD |
Infection | 0.08272435 | 2 | 0 | LHGDN_RGD |
Malignant neoplasm of urinary bladder | 0.082638474 | 2 | 0 | BeFree_GAD_MGD |
Osteoarthritis, Knee | 0.08 | 1 | 0 | RGD |
melanoma | 0.033225155 | 20 | 0 | BeFree_LHGDN |
Adenomatous Polyposis Coli | 0.026912471 | 63 | 2 | BeFree_LHGDN |
Neoplasm Metastasis | 0.019874846 | 18 | 0 | BeFree_LHGDN |
Fibromatosis, Aggressive | 0.018140455 | 30 | 1 | BeFree_GAD_LHGDN |
Squamous cell carcinoma | 0.017160427 | 9 | 0 | BeFree_LHGDN |
Stomach Neoplasms | 0.016346101 | 6 | 0 | LHGDN |
Carcinogenesis | 0.014929303 | 55 | 0 | BeFree |
Colorectal Carcinoma | 0.010586233 | 39 | 1 | BeFree |
Endometriosis | 0.008715934 | 5 | 0 | BeFree_LHGDN |
Esophageal Neoplasms | 0.008087174 | 4 | 0 | BeFree_GAD_LHGDN |
Malignant neoplasm of breast | 0.007991366 | 13 | 0 | BeFree_GAD |
Endometrial Neoplasms | 0.007815732 | 3 | 0 | GAD_LHGDN |
Carcinoma, Endometrioid | 0.007534359 | 10 | 0 | BeFree_GAD_LHGDN |
Carcinoid Tumor | 0.005991584 | 3 | 0 | BeFree_LHGDN |
Focal Nodular Hyperplasia | 0.005720142 | 2 | 0 | BeFree_LHGDN |
Hepatitis B | 0.005167327 | 10 | 0 | BeFree_LHGDN |
fibroma | 0.005091382 | 2 | 0 | GAD_LHGDN |
Mouth Neoplasms | 0.005091382 | 2 | 0 | GAD_LHGDN |
Malignant tumor of colon | 0.004885954 | 18 | 0 | BeFree |
Stomach Carcinoma | 0.004885954 | 18 | 0 | BeFree |
Malignant neoplasm of stomach | 0.004071628 | 15 | 0 | BeFree |
Endometrial Carcinoma | 0.004071628 | 15 | 0 | BeFree |
Breast Carcinoma | 0.004071628 | 15 | 0 | BeFree |
Malignant neoplasm of lung | 0.003995683 | 7 | 0 | BeFree_GAD |
Epithelial ovarian cancer | 0.003452799 | 5 | 0 | BeFree_GAD |
leukemia | 0.003267234 | 3 | 0 | BeFree_LHGDN |
Parathyroid Neoplasms | 0.003267234 | 3 | 0 | BeFree_LHGDN |
polyps | 0.003267234 | 3 | 0 | BeFree_LHGDN |
T-Cell Lymphoma | 0.003267234 | 2 | 0 | BeFree_LHGDN |
Meningioma | 0.002995792 | 2 | 0 | BeFree_LHGDN |
Thyroid Neoplasm | 0.002995792 | 2 | 0 | BeFree_LHGDN |
Primary Effusion Lymphoma | 0.002995792 | 2 | 0 | BeFree_LHGDN |
Adenoid Cystic Carcinoma | 0.00272435 | 1 | 0 | LHGDN |
Cessation of life | 0.00272435 | 1 | 0 | LHGDN |
gallbladder neoplasm | 0.00272435 | 1 | 0 | LHGDN |
Hepatitis | 0.00272435 | 1 | 0 | LHGDN |
Inflammation | 0.00272435 | 1 | 0 | LHGDN |
keratoacanthoma | 0.00272435 | 1 | 0 | LHGDN |
Leukemia, Mast-Cell | 0.00272435 | 1 | 0 | LHGDN |
Metaplasia | 0.00272435 | 1 | 0 | LHGDN |
Bone necrosis | 0.00272435 | 1 | 0 | LHGDN |
Polycythemia Vera | 0.00272435 | 1 | 0 | LHGDN |
Kaposi Sarcoma | 0.00272435 | 1 | 0 | LHGDN |
Thrombocythemia, Essential | 0.00272435 | 1 | 0 | LHGDN |
Mucoepidermoid Carcinoma | 0.00272435 | 1 | 0 | LHGDN |
Endometrial Stromal Tumors | 0.00272435 | 1 | 0 | LHGDN |
Neurodegenerative Disorders | 0.00272435 | 1 | 0 | LHGDN |
Solitary fibrous tumor | 0.00272435 | 1 | 0 | LHGDN |
Kidney Neoplasm | 0.002638474 | 2 | 0 | BeFree_GAD |
Ovarian Carcinoma | 0.002442977 | 9 | 9 | BeFree |
Agenesis of corpus callosum | 0.002442977 | 9 | 1 | BeFree |
Tumors of Adrenal Cortex | 0.002367032 | 1 | 0 | GAD |
Neoplastic Cell Transformation | 0.002367032 | 1 | 0 | GAD |
Head and Neck Neoplasms | 0.002367032 | 1 | 0 | GAD |
Laryngeal neoplasm | 0.002367032 | 1 | 0 | GAD |
Chronic Obstructive Airway Disease | 0.002367032 | 1 | 0 | GAD |
Pharyngeal Neoplasms | 0.002367032 | 1 | 0 | GAD |
Neoplasms, Second Primary | 0.002367032 | 1 | 0 | GAD |
Microsatellite Instability | 0.002367032 | 1 | 0 | GAD |
Adenoma of large intestine | 0.002367032 | 1 | 0 | GAD |
Tumor Progression | 0.001900093 | 7 | 0 | BeFree |
Osteosarcoma | 0.001628651 | 6 | 0 | BeFree |
Adrenal Cortical Adenoma | 0.001628651 | 6 | 0 | BeFree |
Osteosarcoma of bone | 0.001628651 | 6 | 0 | BeFree |
Carcinoma of lung | 0.001628651 | 6 | 0 | BeFree |
Renal Cell Carcinoma | 0.001357209 | 5 | 0 | BeFree |
Pituitary Adenoma | 0.001357209 | 5 | 0 | BeFree |
Malignant neoplasm of liver | 0.001357209 | 5 | 0 | BeFree |
Prostate carcinoma | 0.001357209 | 5 | 0 | BeFree |
Fundic gland polyp | 0.001357209 | 5 | 0 | BeFree |
Malignant neoplasm of endometrium | 0.001085767 | 4 | 0 | BeFree |
Pulmonary Blastoma | 0.001085767 | 4 | 0 | BeFree |
Adamantinous Craniopharyngioma | 0.001085767 | 4 | 0 | BeFree |
Hereditary Nonpolyposis Colorectal Cancer | 0.001085767 | 4 | 0 | BeFree |
Epithelioma | 0.001085767 | 4 | 0 | BeFree |
Uterine Corpus Cancer | 0.001085767 | 4 | 0 | BeFree |
Ameloblastoma | 0.000814326 | 3 | 0 | BeFree |
Brain Neoplasms | 0.000814326 | 3 | 0 | BeFree |
Rectal Carcinoma | 0.000814326 | 3 | 0 | BeFree |
Glioma | 0.000814326 | 3 | 0 | BeFree |
Odontogenic Tumors | 0.000814326 | 3 | 0 | BeFree |
Neuroectodermal Tumor, Primitive | 0.000814326 | 3 | 0 | BeFree |
Papillary thyroid carcinoma | 0.000814326 | 3 | 0 | BeFree |
Parathyroid Adenoma | 0.000814326 | 3 | 0 | BeFree |
Liver and Intrahepatic Biliary Tract Carcinoma | 0.000814326 | 3 | 0 | BeFree |
Papillary cystic tumor | 0.000814326 | 3 | 0 | BeFree |
Malignant mesothelioma | 0.000814326 | 3 | 0 | BeFree |
Sarcoma | 0.000814326 | 3 | 0 | BeFree |
Nephrogenic rest | 0.000814326 | 3 | 0 | BeFree |
Cirrhosis | 0.000814326 | 3 | 0 | BeFree |
Non-Neoplastic Disorder | 0.000814326 | 3 | 0 | BeFree |
Malignant neoplasm of thyroid | 0.000542884 | 2 | 0 | BeFree |
Diabetic Nephropathy | 0.000542884 | 2 | 0 | BeFree |
Fibromatosis | 0.000542884 | 2 | 0 | BeFree |
Glioblastoma | 0.000542884 | 2 | 0 | BeFree |
granulosa cell tumor | 0.000542884 | 2 | 0 | BeFree |
Myeloid Leukemia, Chronic | 0.000542884 | 2 | 0 | BeFree |
Mixed Salivary Gland Tumor | 0.000542884 | 2 | 0 | BeFree |
Monosomy | 0.000542884 | 2 | 0 | BeFree |
Multiple Myeloma | 0.000542884 | 2 | 0 | BeFree |
Degenerative polyarthritis | 0.000542884 | 2 | 0 | BeFree |
Pituitary Diseases | 0.000542884 | 2 | 0 | BeFree |
Schizophrenia | 0.000542884 | 2 | 0 | BeFree |
Cutaneous Melanoma | 0.000542884 | 2 | 0 | BeFree |
Secondary malignant neoplasm of lung | 0.000542884 | 2 | 0 | BeFree |
Undifferentiated carcinoma | 0.000542884 | 2 | 0 | BeFree |
Gastrointestinal Carcinoid Tumor | 0.000542884 | 2 | 0 | BeFree |
Metastatic malignant neoplasm to brain | 0.000542884 | 2 | 0 | BeFree |
Gallbladder Carcinoma | 0.000542884 | 2 | 0 | BeFree |
Anaplastic thyroid carcinoma | 0.000542884 | 2 | 0 | BeFree |
Cervix carcinoma | 0.000542884 | 2 | 0 | BeFree |
Malignant odontogenic tumor | 0.000542884 | 2 | 0 | BeFree |
Chronic liver disease | 0.000542884 | 2 | 0 | BeFree |
Arrhythmogenic Right Ventricular Dysplasia | 0.000542884 | 2 | 0 | BeFree |
Papillary craniopharyngioma | 0.000542884 | 2 | 1 | BeFree |
Thyroid carcinoma | 0.000542884 | 2 | 0 | BeFree |
Mesenchymal Cell Neoplasm | 0.000542884 | 2 | 0 | BeFree |
Hepatocarcinogenesis | 0.000542884 | 2 | 0 | BeFree |
Microcystic stromal tumor | 0.000542884 | 2 | 0 | BeFree |
Congenital Abnormality | 0.000271442 | 1 | 0 | BeFree |
Astrocytoma | 0.000271442 | 1 | 0 | BeFree |
Benign neoplasm of skin | 0.000271442 | 1 | 0 | BeFree |
Noninfiltrating Intraductal Carcinoma | 0.000271442 | 1 | 0 | BeFree |
Non-Small Cell Lung Carcinoma | 0.000271442 | 1 | 0 | BeFree |
Cholestasis | 0.000271442 | 1 | 0 | BeFree |
Ulcerative Colitis | 0.000271442 | 1 | 0 | BeFree |
Colonic Polyps | 0.000271442 | 1 | 0 | BeFree |
DiGeorge Syndrome | 0.000271442 | 1 | 0 | BeFree |
Gardner Syndrome | 0.000271442 | 1 | 0 | BeFree |
Gastrointestinal Neoplasms | 0.000271442 | 1 | 0 | BeFree |
hemangiopericytoma | 0.000271442 | 1 | 0 | BeFree |
Hematological Disease | 0.000271442 | 1 | 0 | BeFree |
HIV Infections | 0.000271442 | 1 | 0 | BeFree |
Hyperparathyroidism | 0.000271442 | 1 | 0 | BeFree |
insulinoma | 0.000271442 | 1 | 0 | BeFree |
Intestinal Polyps | 0.000271442 | 1 | 0 | BeFree |
Fibroid Tumor | 0.000271442 | 1 | 0 | BeFree |
Chronic Lymphocytic Leukemia | 0.000271442 | 1 | 0 | BeFree |
Acute lymphocytic leukemia | 0.000271442 | 1 | 0 | BeFree |
Leukemia, Myelocytic, Acute | 0.000271442 | 1 | 0 | BeFree |
Liver diseases | 0.000271442 | 1 | 0 | BeFree |
Mesothelioma | 0.000271442 | 1 | 0 | BeFree |
Metabolic Diseases | 0.000271442 | 1 | 0 | BeFree |
Muscle Spasticity | 0.000271442 | 1 | 0 | BeFree |
Osteoblastoma | 0.000271442 | 1 | 0 | BeFree |
Peutz-Jeghers Syndrome | 0.000271442 | 1 | 0 | BeFree |
Precancerous Conditions | 0.000271442 | 1 | 0 | BeFree |
Retinoblastoma | 0.000271442 | 1 | 0 | BeFree |
Sertoli Cell Tumor | 0.000271442 | 1 | 0 | BeFree |
Skin Neoplasms | 0.000271442 | 1 | 0 | BeFree |
Trisomy | 0.000271442 | 1 | 0 | BeFree |
Uterine Fibroids | 0.000271442 | 1 | 0 | BeFree |
Virus Diseases | 0.000271442 | 1 | 0 | BeFree |
Adenocarcinoma of lung (disorder) | 0.000271442 | 1 | 0 | BeFree |
Adenoma, Microcystic | 0.000271442 | 1 | 0 | BeFree |
Ossifying Fibroma | 0.000271442 | 1 | 0 | BeFree |
Fibromatosis, Abdominal | 0.000271442 | 1 | 0 | BeFree |
Sebaceous Adenocarcinoma | 0.000271442 | 1 | 0 | BeFree |
Acinar Cell Carcinoma | 0.000271442 | 1 | 0 | BeFree |
Hyperparathyroidism, Primary | 0.000271442 | 1 | 0 | BeFree |
Small intestine carcinoma | 0.000271442 | 1 | 0 | BeFree |
Turcot syndrome (disorder) | 0.000271442 | 1 | 0 | BeFree |
Endometrioma | 0.000271442 | 1 | 0 | BeFree |
Spastic syndrome | 0.000271442 | 1 | 0 | BeFree |
Muscular Dystrophy, Oculopharyngeal | 0.000271442 | 1 | 0 | BeFree |
Cervical Adenocarcinoma | 0.000271442 | 1 | 0 | BeFree |
Extraosseous Ewings sarcoma-primitive neuroepithelial tumor | 0.000271442 | 1 | 0 | BeFree |
Hamartomatous polyp | 0.000271442 | 1 | 0 | BeFree |
Endometrioid carcinoma ovary | 0.000271442 | 1 | 0 | BeFree |
Malignant neoplasm of adrenal cortex | 0.000271442 | 1 | 0 | BeFree |
Multiple malignancy | 0.000271442 | 1 | 0 | BeFree |
Secondary malignant neoplasm of liver | 0.000271442 | 1 | 0 | BeFree |
Leukemogenesis | 0.000271442 | 1 | 0 | BeFree |
invasive cancer | 0.000271442 | 1 | 0 | BeFree |
Ewings sarcoma-primitive neuroectodermal tumor (PNET) | 0.000271442 | 1 | 0 | BeFree |
Secondary malignant neoplasm of lymph node | 0.000271442 | 1 | 0 | BeFree |
Carcinoma of bladder | 0.000271442 | 1 | 0 | BeFree |
Skin carcinoma | 0.000271442 | 1 | 0 | BeFree |
Dissecting aneurysm of the thoracic aorta | 0.000271442 | 1 | 0 | BeFree |
Malignant neoplasm of kidney | 0.000271442 | 1 | 0 | BeFree |
Stromal Neoplasm | 0.000271442 | 1 | 1 | BeFree |
Squamous cell carcinoma of the head and neck | 0.000271442 | 1 | 0 | BeFree |
Transitional cell dysplasia | 0.000271442 | 1 | 0 | BeFree |
Atypical polypoid adenomyoma | 0.000271442 | 1 | 0 | BeFree |
Biphasic Pulmonary Blastoma | 0.000271442 | 1 | 0 | BeFree |
Endometrial intraepithelial neoplasia | 0.000271442 | 1 | 0 | BeFree |
Invasive Carcinoma | 0.000271442 | 1 | 0 | BeFree |
Pancreatic Ductal Adenocarcinoma | 0.000271442 | 1 | 0 | BeFree |
Well Differentiated Pancreatic Endocrine Tumor | 0.000271442 | 1 | 0 | BeFree |
Granulosa cell tumor of the ovary | 0.000271442 | 1 | 0 | BeFree |
Renal carcinoma | 0.000271442 | 1 | 0 | BeFree |
Mammary Tumorigenesis | 0.000271442 | 1 | 0 | BeFree |
Pneumocystis jiroveci pneumonia | 0.000271442 | 1 | 0 | BeFree |
Adenocarcinoma, Endometrioid | 0.000271442 | 1 | 0 | BeFree |
Gardner fibroma | 0.000271442 | 1 | 0 | BeFree |
Hereditary Diffuse Gastric Cancer | 0.000271442 | 1 | 0 | BeFree |
MYELOPROLIFERATIVE SYNDROME, TRANSIENT | 0.000271442 | 1 | 0 | BeFree |
ECTRODACTYLY, ECTODERMAL DYSPLASIA, AND CLEFT LIP/PALATE SYNDROME 1 | 0.000271442 | 1 | 0 | BeFree |
Trichohepatoenteric Syndrome | 0.000271442 | 1 | 0 | BeFree |
Endometrial stromal sarcoma, high grade | 0.000271442 | 1 | 0 | BeFree |
Hepatitis B and hepatitis C | 0.000271442 | 1 | 0 | BeFree |
Glycogen storage disease type Ia | 0.000271442 | 1 | 0 | BeFree |
Chronic ulcerative colitis | 0.000271442 | 1 | 0 | BeFree |
Palisaded myofibroblastoma | 0.000271442 | 1 | 0 | BeFree |
Small Intestinal Neuroendocrine Tumor | 0.000271442 | 1 | 0 | BeFree |
Intellectual Disability | 0.000271442 | 1 | 0 | BeFree |
Experimental Organism Basal Cell Carcinoma | 0.000271442 | 1 | 0 | BeFree |
忘记密码? 点击找回密码.
扫一扫右方二维码,关注微信订阅号,实时查看信息,关注医学生物学动态。